Comparison of Conventional Beta-Blockers and A New Pioneer, Mavacamten (MYK-461): A Cardiac Myosin Modulator, in Management of Hypertrophic Obstructive Cardiomyopathy

Jawad Rao,

Published on: 2022-10-15

Abstract

scroll up